SUMITOMO PHARMA CO.,LTD.SUMITOMO PHARMA CO.,LTD.SUMITOMO PHARMA CO.,LTD.

SUMITOMO PHARMA CO.,LTD.

No trades
See on Supercharts

DPM fundamentals

An in-depth look to SUMITOMO PHARMA CO.,LTD. operating, investing, and financing activities

DPM free cash flow for Q3 23 is -375.43 M EUR. For 2022, DPM free cash flow was 24.1 M EUR and operating cash flow was 82.9 M EUR.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
TTM
Free cash flowYoY growth